Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cutting edge: small molecule CD40 ligand mimetics promote control of parasitemia and enhance T cells producing IFN-gamma during experimental Trypanosoma cruzi infection.
Habib M, Noval Rivas M, Chamekh M, Wieckowski S, Sun W, Bianco A, Trouche N, Chaloin O, Dumortier H, Goldman M, Guichard G, Fournel S, Vray B. Habib M, et al. Among authors: goldman m. J Immunol. 2007 Jun 1;178(11):6700-4. doi: 10.4049/jimmunol.178.11.6700. J Immunol. 2007. PMID: 17513713
Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection.
Chamekh M, Vercruysse V, Habib M, Lorent M, Goldman M, Allaoui A, Vray B. Chamekh M, et al. Among authors: goldman m. Infect Immun. 2005 Oct;73(10):6552-61. doi: 10.1128/IAI.73.10.6552-6561.2005. Infect Immun. 2005. PMID: 16177330 Free PMC article.
We have previously shown that infection by Trypanosoma cruzi, a parasitic protozoan, is reduced by injection of CD40 ligand (CD40L)-transfected 3T3 fibroblasts (D. Chaussabel, F. Jacobs, J. de Jonge, M. de Veerman, Y. Carlier, K. Thielemans, M. Goldman, and B …
We have previously shown that infection by Trypanosoma cruzi, a parasitic protozoan, is reduced by injection of CD40 ligand (CD40L)-transfec …
Reviving function in CD4+ T cells adapted to persistent systemic antigen.
Noval Rivas M, Weatherly K, Hazzan M, Vokaer B, Dremier S, Gaudray F, Goldman M, Salmon I, Braun MY. Noval Rivas M, et al. Among authors: goldman m. J Immunol. 2009 Oct 1;183(7):4284-91. doi: 10.4049/jimmunol.0901408. Epub 2009 Sep 4. J Immunol. 2009. PMID: 19734216
3,349 results